Related Experiment Video
Updated: Apr 27, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
HIV-1 and GBV-C co-infection in Venezuela
Anny Karely Rodríguez1, Domingo José Garzaro, Carmen Luisa Loureiro
1Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela. akrodrig@gmail.com.
Insights
GB virus C (GBV-C) co-infection is more prevalent in HIV-1 patients in Venezuela. This co-infection impacts viral load and alters the cytokine environment, suggesting a complex role in disease progression.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Co-infection with GB virus C (GBV-C) and human immunodeficiency virus 1 (HIV-1) is linked to better survival outcomes.
- Understanding the prevalence and immunological impact of this co-infection in specific populations is crucial.
Purpose of the Study:
- To determine the prevalence of GBV-C infection in HIV-1-infected individuals in Venezuela.
- To investigate the effects of GBV-C/HIV-1 co-infection on cytokine profiles.
Main Methods:
- RT-PCR and sequence analysis were used to detect and genotype GBV-C.
- HIV-1 strains were characterized by gene sequence analysis.
- Cytokine levels (TNFα, RANTES) were measured using ELISA.
Main Results:
- GBV-C RNA was detected in 18.5% of 525 individuals.
- Prevalence of GBV-C was significantly higher in HIV-1-positive individuals (26%) compared to HIV-1-negative individuals (11%).
- Co-infection affected viral load and altered TNFα and RANTES levels, with notable differences between mono- and co-infected groups.
Conclusions:
- The beneficial effect of GBV-C/HIV-1 co-infection on disease progression is complex and may involve modulation of the cytokine environment.
- Further research is needed to elucidate the intricate interactions between GBV-C and HIV-1.
Introduction:
Co-infection with GB virus C (GBV-C) in patients infected with human immunodeficiency virus 1 (HIV-1) has been associated with prolonged survival. The aim of this study was to evaluate the prevalence of GBV-C infection among HIV-1-infected patients in Venezuela, and to determine the effects of the co-infection on the levels of relevant cytokines.
Methodology:
Plasma samples were collected from 270 HIV-1-seronegative and 255 HIV-1-seropositive individuals. GBV-C infection was determined by RT-PCR of the NS5 region and genotyped by sequence analysis of the 5´UTR region. HIV-1 strains were characterized by sequence analysis of pol, vif, env, and nef genes. Selected cytokines were evaluated by ELISA.
Results:
Ninety-seven of 525 (18.5%) plasma samples tested positive for GBV-C RNA. A significantly higher prevalence of GBV-C was found among HIV-1 patients compared to HIV-1-seronegative individuals (67/255, 26% versus 30/270, 11%; p < 0.001). Statistical difference was observed in the viral load between HIV-1+GBV-C+ and HIV-1+GBV-C- (p = 0.014), although no differences in CD4+ cell counts were found between both groups. TNFα concentration was higher in HIV-1+GBV-C- than in HIV-1+GBV-C+ patients (25.9 pg/mL versus 17.3 pg/mL; p = 0.02); RANTES expression levels were more variable in GBV-C co-infected patients and more frequently elevated in HIV-1 mono-infected patients compared to patients co-infected with GBV-C.
Conclusions:
The previously observed beneficial effect of co-infection with HIV-1 and GBV-C on disease progression is complex and might be due in part to a change in the cytokine environment. More studies are required to understand the interaction between both viruses.
More Related Videos
07:39An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Related Concept Videos
Cytomegalovirus Disease
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Viral Hepatitis I: Introduction
Arboviral Encephalitis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...